Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Centre for Food and Genomic Medicine (CFGM) is a translational research organization based in Hong Kong, established by The Chinese University of Hong Kong under the government's InnoHK initiative. The center focuses on the intersection of genomics, gut microbiome, and nutrition to develop personalized medicine solutions for metabolic diseases such as diabetes and obesity. By leveraging large-scale multi-omics data and advanced bioinformatics, CFGM aims to identify novel biomarkers and therapeutic targets to improve disease prevention and management. Its research portfolio includes the development of microbiome-based diagnostics and live biotherapeutic products tailored for the Asian population. CFGM operates as a bridge between basic scientific discovery and clinical application, collaborating with global academic institutions and industry partners to advance precision medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Centre for Food and Genomic Medicine.